ICD-10-CM Code C91.31

Prolymphocytic leukemia of B-cell type, in remission

Version 2021 Billable Code

Valid for Submission

C91.31 is a billable code used to specify a medical diagnosis of prolymphocytic leukemia of b-cell type, in remission. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code C91.31 might also be used to specify conditions or terms like b-cell prolymphocytic leukemia or b-cell prolymphocytic leukemia in remission or lymphoid leukemia in remission or prolymphocytic leukemia .

ICD-10:C91.31
Short Description:Prolymphocytic leukemia of B-cell type, in remission
Long Description:Prolymphocytic leukemia of B-cell type, in remission

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • B-cell prolymphocytic leukemia
  • B-cell prolymphocytic leukemia in remission
  • Lymphoid leukemia in remission
  • Prolymphocytic leukemia

Diagnostic Related Groups

The ICD-10 code C91.31 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2021.

  • 820 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC
  • 821 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC
  • 822 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC

Convert C91.31 to ICD-9

  • 204.81 - Oth lym leuk w rmsion (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
      • Lymphoid leukemia (C91)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Information for Patients


Chronic Lymphocytic Leukemia

Also called: CLL

Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. In chronic lymphocytic leukemia (CLL), there are too many lymphocytes, a type of white blood cell.

CLL is the second most common type of leukemia in adults. It often occurs during or after middle age, and is rare in children.

Usually CLL does not cause any symptoms. If you have symptoms, they may include

  • Painless swelling of the lymph nodes in the neck, underarm, stomach, or groin
  • Fatigue
  • Pain or a feeling of fullness below the ribs
  • Fever and infection
  • Weight loss

Tests that examine the blood, bone marrow, and lymph nodes diagnose CLL. Your doctor may choose to just monitor you until symptoms appear or change. Treatments include radiation therapy, chemotherapy, surgery to remove the spleen, and targeted therapy. Targeted therapy uses substances that attack cancer cells or block the growth and spread of cancer cells.

NIH: National Cancer Institute

  • After chemotherapy - discharge (Medical Encyclopedia)
  • B-cell leukemia/lymphoma panel (Medical Encyclopedia)
  • Bone marrow transplant (Medical Encyclopedia)
  • Bone marrow transplant - discharge (Medical Encyclopedia)
  • Chronic lymphocytic leukemia (CLL) (Medical Encyclopedia)

[Learn More]